Publications

• Inhibition of Dendritic Cell Activation and Modulation of T Cell Polarization by the Platelet Secretome
  Saris et al., 2021, Frontiers in Immunology
• Clinically applicable CD34+ ‑derived blood dendritic cell subsets exhibit key subset‑specific features and potently boost anti‑tumor T and NK cell responses
  van Eck van der Sluijs, J. et al., 2021, Cancer Immunology, Immunotherapy
• The importance of material selection in the differentiation of monocytes into dendritic cells
  Boghosian et al., 2018, Cell & Gene Therapy Insights
• A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
  Jung, SH. et al., 2017, Oncotarget
• Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
  Bell, GM. Et al., 2017, Annals of the Rheumatic Diseases
• Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions
  Velaga, S. et al., 2017, Experimental Hematology
• Adaptation to replating of dendritic cells synergizes with Toll-like receptor stimuli and enhances the pro-inflammatory cytokine profile
  Kolanwoski, ST. et al., 2016, Cytotherapy
• Transfecting human monocytes with RNA
  Dannull, J. et al., 2016, Methods in molecular biology
• Efficient Virus Assembly, but Not Infectivity, Determines the Magnitude of Hepatitis C Virus-Induced Interferon Alpha Responses of Plasmacytoid Dendritic Cells
  Grabski, E. et al., 2015, Journal of Virology
• ELISpot and DC-ELISpot Assay to Measure Frequency of Antigen-Specific IFN γ-Secreting Cells
  Navarrette, MA. et al., 2015, Methods in Molecular Biology
• A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation
  Ruben, JM. et al., 2015, PloS One
• Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death
  Vogel, S. et al., 2015, Cell Death and Differentiation
• Comparison of media and serum supplementation for generation of monophosphoryl lipid A/interferon-γ-matured type I dendritic cells for immunotherapy
  Kolanowski, ST. et al., 2014, Cytotherapy
• Antigen-specific activation and cytokine-faciliated expansion of naive, human CD8+ T cells
  Wölfl, M., Greenberg, PD., 2014, Nature Protocols
• A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
  Poschke, I. et al., 2014, Cancer Immunology, Immunotherapy
• Usage of standardized antigen-presenting cells improves ELISpot performance for complex protein antigens
  Navarrete, MA. et al., 2013, Journal of Immunological Methods
• Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
  Hansen, M. et al., 2013, Vaccine
• Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells
  Lazarova, P. et al., 2012, Immunodeficiency, Chapter 3
• Optimizing parameters for clinical -scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor lysate
  Chiang, CL. et al., 2011, Journal of translational medicine
• Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
  Fučíková, J. et al., 2011, Journal of translational medicine
• Transiently redirected T cells for adoptive transfer
  Almåsbak, H. et al., 2011, Cytotherapy
• Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile
  Gustafsson, K. et al., 2011, Scandinavian journal of immunology
• Autologous dendritic cell vaccine for chronic hepatitis B carriers: a pilot, open label, clinical trial in human volunteers
  Luo, J. et al., 2010, Vaccine
• Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome
  Venanzi, FM. et al., 2010, Cancer, Immunology, Immunotherapy
• Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells
  Kalinski, P. et al., 2010, Methods in molecular biology
• Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
  Drohnal, AM. et al., 2009, Journal of cellular and molecular medicine
• Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
  Lee, JJ. et al., 2008, Journal of leukocyte biology
• A comparative analysis of serum and serum-free media for generation of clinical grade DCs
  Napoletano, C. et al., 2007, Journal of immunotherapy
• Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells
  Mu, LJ. et al., 2004, International Journal of Immunopathology and Pharmacology